Stay updated on Ruxolitinib vs BAT in Chronic GvHD Clinical Trial
Sign up to get notified when there's something new on the Ruxolitinib vs BAT in Chronic GvHD Clinical Trial page.

Latest updates to the Ruxolitinib vs BAT in Chronic GvHD Clinical Trial page
- CheckyesterdayChange DetectedThe page now displays an updated site revision marker (v3.5.2 instead of v3.5.0). This reflects a technical site/version update without changing the study information shown.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedRevision history updated: added v3.5.0 and removed v3.4.3.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 in the page header. This appears to be a minor version update and does not modify study details.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page shows a small revision update from v3.4.1 to v3.4.2 with no obvious changes to study details or page behavior. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check74 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0, indicating a minor document version update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check88 days agoChange DetectedMinor UI/metadata updates include a new 'Show glossary' option, capitalization tweaks to QC-related labels (e.g., 'Last Update Submitted that Met QC Criteria'), and a revision from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Ruxolitinib vs BAT in Chronic GvHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ruxolitinib vs BAT in Chronic GvHD Clinical Trial page.